Clinical Trials Browser

Phase 1/2 × asciminib × Gastrointestinal × Clear all

NCT04492033 2025-01-27

A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients

Phase 1/2 Terminated

GastrointestinalOther solid neoplasm

P1b: Advanced Solid Tumors